+91-8668442535

Umbilical Cord Blood Banking Market By Storage (Public Cord Blood Banks And Private Cord Blood Banks), By Type Of Application (Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders, And Osteopetrosis) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

The report titled "Umbilical Cord Blood Banking Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" offers strategic insights into the overall umbilical cord blood banking market, along with the market size and estimates for the duration of 2015–2025. The said research study covers an in-depth analysis of multiple market segments based on the type of storage, application, and different geographies. Umbilical cord and placental blood are rich in stem cells that can be used to treat diseases such as leukemia, lymphoma, myeloma, aplastic anemia, and certain immunologic and metabolic disorders. Cord blood is considered the safest option compared to other stem cell sources due to its non-invasiveness and minimal risk to the mother and child.

For the purpose of this study, the global umbilical cord blood banking market is segmented on the basis of storage type into private cord blood banks and public cord blood banks. Market size estimates and forecasts for these segments for the period 2015–2025 are provided in terms of USD million, along with the respective compounded annual growth rates (CAGRs) for the period 2017–2025, considering 2016 as the base year.

The global umbilical cord blood banking market is also segmented on the basis of types of applications such as cancer, blood disorders, metabolic disorders, immune disorders, and osteoporosis. Market size estimates and forecasts for these segments for the period 2015–2025 are provided in terms of USD million, along with the respective compounded annual growth rates (CAGRs) for the period 2017–2025, considering 2016 as the base year.

The geographical segmentation of the umbilical cord blood banking market comprised regions such as North America, Europe, Asia-Pacific, Latin America & the Middle East, and Africa. Each geographical region is further split to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, Brazil, Mexico, Saudi Arabia, South Africa, and other countries. The market size and forecast for these segments during 2015–2025 and their CAGRs for the period 2017–2025 are provided in this report.

The umbilical cord blood banking market is observed as the most diversified and competitive market, comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are CBR Systems, Inc., ViaCord Inc., China Cord Blood Corporation, Cord Blood America, Inc., Cryo-Cell International, Inc., Cryo-Save AG, Cordlife Group Ltd., Vita 34 AG, LifeCell, and StemCyte Inc., among others.

Based on the type of storage, the global umbilical cord blood banking market is segmented as follows:

  • Private cord blood banks
  • Public cord blood banks

In 2016, private cord blood banks were observed as the largest segment due to key driving factors such as complete ownership rights secured by the donor, widespread collection sites, and high assurance related to the security and storage facilities. On the other hand, public cord blood banks collect and store cord blood-derived stem cells but do not process and store cord tissue stem cells. According to Cryocell International, in the case of public cord blood banks, it has been observed that approximately 70% of cord blood donated to public banks is discarded for not meeting processing and storage criteria. Thus, demand and preference for private banks are expected to increase in the near future.

Based on the type of application, the global umbilical cord blood banking market is segmented as follows:

  • Cancer
  • Blood Disorders
  • Metabolic Disorders
  • Immune Disorders
  • Osteopetrosis
  • Others

The rising prevalence of cancer, rising demand for stem cell therapy in cancer treatment, developing research activities in the field of cancer treatment, and increasing awareness associated with an early cancer diagnosis are the key factors driving the overall cord blood banking market. In 2016, cancer was observed as the largest application segment in the global umbilical cord blood banking market. According to Cancer Research UK, in 2012, an estimated 14.1 million new cases of cancer occurred worldwide, and more than 4 in 10 cancers occurring worldwide are in countries with a low or medium level of the Human Development Index (HDI). Furthermore, the four most common cancers in the world are lung cancer, female breast cancer, bowel cancer, and prostate cancer. Thus, the demand for safe and effective cancer therapies is high, and most hematological cancers are being treated with stem cell therapy.

For the purpose of this study, the global umbilical cord blood banking market is categorized into three segments:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

In the base year 2016, North America accounted for the largest share in the global umbilical cord blood banking market due to key driving factors such as rising demand for cord blood in stem cell research, increasing awareness related to the benefits of cord blood banking, developed research and healthcare infrastructure, and incessant development in the field of storage and application of stem cells extracted from cord blood. During the forecast period of 2017–2025, Asia Pacific was observed as the most potential market due to rising public awareness related to the advantages of cord blood banking, many untapped markets, and increasing government support and initiatives. The potential of cord blood stem cells for regenerative therapies has encouraged the number of cord blood banks in Asia. However, apart from countries like Japan and Singapore, other countries such as China, Vietnam, South Korea, Malaysia, India, and Taiwan also claim to have their own cord blood banks.

Frequently Asked Question:

The market for Umbilical Cord Blood Banking Market is expected to reach USD$ 7,623.3 Mn in 2025.

The Umbilical Cord Blood Banking Market is expected to see significant CAGR growth over the coming years, at 11.3%.

The report is forecasted from 2017 -2025.

The base year of this report is 2016.

CBR Systems, Inc., ViaCord Inc., China Cord Blood Corporation, Cord Blood America, Inc., Cryo-Cell International, Inc., Cryo-Save AG, Cordlife Group Ltd. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Sep 2017
Category:  Medical Devices
Report ID:   58662
Report Format:   PDF
Pages:   120
Rating:    4.5 (60)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support